4-55442520-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004898.4(CLOCK):​c.2017G>A​(p.Gly673Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,608,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 27)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

CLOCK
NM_004898.4 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.88

Publications

6 publications found
Variant links:
Genes affected
CLOCK (HGNC:2082): (clock circadian regulator) The protein encoded by this gene plays a central role in the regulation of circadian rhythms. The protein encodes a transcription factor of the basic helix-loop-helix (bHLH) family and contains DNA binding histone acetyltransferase activity. The encoded protein forms a heterodimer with ARNTL (BMAL1) that binds E-box enhancer elements upstream of Period (PER1, PER2, PER3) and Cryptochrome (CRY1, CRY2) genes and activates transcription of these genes. PER and CRY proteins heterodimerize and repress their own transcription by interacting in a feedback loop with CLOCK/ARNTL complexes. Polymorphisms in this gene may be associated with behavioral changes in certain populations and with obesity and metabolic syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
TMEM165 (HGNC:30760): (transmembrane protein 165) This gene encodes a predicted transmembrane protein with a perinuclear Golgi-like distribution in fibroblasts. Mutations in this gene are associated with the autosomal recessive disorder congenital disorder of glycosylation, type IIk. Knockdown of this gene's expression causes decreased sialylation in HEK cells and suggests this gene plays a role in terminal Golgi glycosylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
TMEM165 Gene-Disease associations (from GenCC):
  • TMEM165-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09729931).
BS2
High AC in GnomAd4 at 34 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLOCKNM_004898.4 linkc.2017G>A p.Gly673Arg missense_variant Exon 21 of 23 ENST00000513440.6 NP_004889.1 O15516Q53EU0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLOCKENST00000513440.6 linkc.2017G>A p.Gly673Arg missense_variant Exon 21 of 23 1 NM_004898.4 ENSP00000426983.1 O15516

Frequencies

GnomAD3 genomes
AF:
0.000231
AC:
34
AN:
146902
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.000279
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000693
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000100
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000313
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000251
AC:
63
AN:
251298
AF XY:
0.000177
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000440
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000211
AC:
308
AN:
1461832
Hom.:
0
Cov.:
31
AF XY:
0.000208
AC XY:
151
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.0000894
AC:
4
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000255
AC:
283
AN:
1111968
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000231
AC:
34
AN:
147020
Hom.:
0
Cov.:
27
AF XY:
0.000126
AC XY:
9
AN XY:
71326
show subpopulations
African (AFR)
AF:
0.000278
AC:
11
AN:
39538
American (AMR)
AF:
0.0000692
AC:
1
AN:
14446
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3426
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5000
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4342
European-Finnish (FIN)
AF:
0.000100
AC:
1
AN:
9994
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000313
AC:
21
AN:
67102
Other (OTH)
AF:
0.00
AC:
0
AN:
1980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000330
Hom.:
0
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.000218
EpiControl
AF:
0.000296

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 28, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2017G>A (p.G673R) alteration is located in exon 21 (coding exon 18) of the CLOCK gene. This alteration results from a G to A substitution at nucleotide position 2017, causing the glycine (G) at amino acid position 673 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.049
T;T;T
Eigen
Benign
0.080
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.89
D;.;.
M_CAP
Benign
0.0098
T
MetaRNN
Benign
0.097
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L;L
PhyloP100
1.9
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.20
N;N;N
REVEL
Benign
0.12
Sift
Uncertain
0.014
D;D;D
Sift4G
Benign
0.62
T;T;T
Polyphen
0.55
P;P;P
Vest4
0.52
MutPred
0.18
Gain of MoRF binding (P = 0.0256);Gain of MoRF binding (P = 0.0256);Gain of MoRF binding (P = 0.0256);
MVP
0.17
MPC
0.93
ClinPred
0.047
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.47
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145873359; hg19: chr4-56308687; COSMIC: COSV59401488; API